Search Results

1 - 10 of 33 items :

  • canine stem cells x
Clear All
Canine Amniotic Membrane Derived Mesenchymal Stem Cells- Potential Sources for Regenerative Medicine

References Fernandes R.A., Wenceslau C.V., Reginato A.L., Kerkis I., Miglino M. A., 2012. Derivation and characterization of progenitor stem cells from canine allantois and amniotic fluids at the third trimester of gestation.Placenta, Aug; 33(8):640-4. Kaviani A, Perry TE, Dzakovic A et al. 2001. The AF as a source of cells for fetal tissue engineering. Journal of Pediatric Surgery 36, 1662-1665. Yu S., Tajiri N., Franzese N., Franzblau M., Bae E., Platt S., Kaneko Y., Borlongan C.V, 2013. Stem cell-like dog

Open access
Canine Adipose-Derived Stem Cell Aggregates as a Viable Substitute to Actual Canine Dermal Papillae

. (2007). Determination of hair structure and shape. Semin Cell Dev Biol, 18(2): 267-273. http://dx.doi.org/10.1016/j.semcdb.2007.01.005 PMid:17324597 17. Kim, H., Choi, K., Kweon, OK., Kim, WH. (2012). Enhanced wound healing effect of canine adiposederived mesenchymal stem cells with low-level laser therapy in athymic mice. J Dermatol Sci, 68(3): 149-156. http://dx.doi.org/10.1016/j.jdermsci.2012.09.013 PMid:23084629 18. Ryu, HH., Lim, JH., Byeon, YE. et al. (2009

Open access
Characterisation and In Vivo Safety of Canine Adipose-Derived Stem Cells

inquiry. Nature , 468 , 485. de Bakker, E., Van Ryssen, B., De Schauwer, C., Meyer, E. (2013). Canine mesenchymal stem cells: State of the art, perspectives as therapy for dogs and as a model for man. Vet. Quart. , 33 , 225–233. De Jesus, M. M., Santiago, J. S., Trinidad, C. V., See, M. E., Semon, K. R., Fernandez, M. O., Jr., Chung, F. S. (2016). Autologous adipose-derived mesenchymal stromal cells for the treatment of Psoriasis vulgaris and psoriatic arthritis: A case report. Cell Transplant. , 25 , 2063–2069. Desiderio, V., De Francesco, F

Open access
The use of mesenchymal stem cells in veterinary medicine

;59(9):1182-1187. 4. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies. TISSUE Eng. 2001;7(2). 5. Wu P, Sato K, Yukawa S, Hikasa Y, Kagota K. Differentiation of Stromal-Vascular Cells Isolated from Canine Adipose Tissues in Primary Culture. J Vet Med Sci. 2001;63(1):17-23; DOI:10.1292/jvms.63.17. 6. Young HE, Black AC. Adult stem cells. Anat Rec. 2004;276A(1):75-102; DOI:10.1002/ar.a.10134. 7. Chen KG, Mallon BS, McKay RDG, Robey PG. Human

Open access
Kit Receptor Expression in Canine Cutaneous Mast Cell Tumors (CMCTs) Without C-Kit Mutation

Tumors and Receptor Tyrosine Kinase Profiling. The University of Guelph; 2012. 16. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L: Canine mast cell tumors express stem cell factor receptor. The American Journal of dermatopathology 2000, 22(1):49-54. 17. Preziosi R, Morini M, Sarli G: Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2004, 16

Open access
Morphological Features and KIT Receptor Expression in Canine Cutaneous Mast Cell Tumor and Systemic Mastocytosis / Morfološke Karakteristike I Ekspresija KIT Receptora Kod Kutanih Mastocitoma I Sistemske Mastocitoze Pasa

. 9. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V: The use of kit and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 2004, 41(4):371-377. 10. Gil da Costa RM, Matos E, Rema A, Lopes C, Pires MA, Gartner F: CD117 immunoexpression in canine mast cell tumors: correlations with pathological variables and proliferation markers. BMC Veterinary Research 2007, 21(3):19. 11. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L: Canine mast cell tumors express stem cell factor

Open access
Evaluation of a canine transmissible venereal tumour cell line with tumour immunity capacity but without tumorigenic property

References 1. Adams E.W., Carter L.P., Sapp W.J.: Growth and maintenance of the canine venereal tumor in continuous culture. Cancer Res 1968, 28, 753–757. 2. Antonov A.: Successful treatment of canine transmissible venereal tumor using vincristine sulfate. Adv Res 2015, 5, 1–5. 3. Bloom F., Paff G.H., Nobace C.R.: The transmissible venereal tumor of the dog. Studies indicating that the tumor cells are mature end cells of reticulo-endothelial origin. Am J Pathol 1950, 27, 119–139. 4. Ching Y.L., His H.L., Ming J.T., Wang Y.K.: Vimentin

Open access
Immunophenotypic characterisation and cytogenetic analysis of mesenchymal stem cells from equine bone marrow and foal umbilical cords during in vitro culture

chromatid exchange incidence in domestic horse chromosomes (Equus caballus). Folia Biol (Krakow) 2013, 61, 199–204. 24. Zucconi E., Vieira N.M., Bueno D.F., Secco M., Jazedje T., Ambrosio C.E., Passos-Bueno M.R., Miglino M.A., Zatz M.: Mesenchymal stem cells derived from canine umbilical cord vein – A novel source for cell therapy studies. Stem Cells Dev 2010, 19, 395–402.

Open access
The Blood is Rich in Different Types of Mesoderm Derived Stem and Progenitor Cells

: Alveolar bone regeneration around immediate implants using an injectable nHAC/CSH loaded with autogenic bloodacquired mesenchymal progenitor cells: an experimental study in the dog mandible. Clin Implant Dent Relat Res. 2013, 15(3):390-401. 87. Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM, Kim WH, Kweon OK: Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton’s jelly for treating bone defects. J Vet Sci. 2012, 13(3):299-310. 88. Ryu HH

Open access
The Role of Tumor Microenvironment and Impact of Cancer Stem Cells on Breast Cancer Progression and Growth

, Li ZS, Zhang HZ, Zheng PJ, Li QL, Shi JG, Yan QG, Ye J, Wang JB, Guo Y, Huang XF, Yu YH. Invasive cancers are not necessarily from preformed in situ tumours - an alternative way of carcinogenesis from misplaced stem cells. J Cell Mol Med. 2013;17(7):921-6. 41. Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O’Brien TD, Sharkey LC, Modiano JF, Dickerson EB. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol. 2014

Open access